[1] 秦小英, 刘慧, 韩冲芳, 等. 改善昼夜节律紊乱减轻糖尿病大鼠心肌缺血/再灌注损伤[J]. 基础医学与临床, 2024, 44:231-234. [2] Huang Q, Tian H, Tian L, et al. Inhibiting Rev-erbα-mediated ferroptosis alleviates susceptibility to myocardial ischemia-reperfusion injury in type 2 diabetes[J]. Free Radic Biol Med, 2023, 209:135-150. [3] Cheng XY, Gu XY, Gao Q, et al. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury[J]. Mol Med Rep, 2016, 14:797-803. [4] Cheng X, Hu J, Wang Y, et al. Effects of dexmedetomidine postconditioning on myocardial ischemia/reperfusion injury in diabetic rats: role of the PI3K/Akt-dependent signaling pathway[J]. J Diabetes Res, 2018, 2018:3071959-3071968. [5] Jiang J, Xu J, Tang H. miR-490-3p alleviates cardiomyocyte injury via targeting FOXO1[J]. Protein Pept Lett, 2022, 29:917-924. [6] 马振旺, 姜德友, 胡丙成, 等. 橙皮苷通过SIRT1/Nrf2/HO-1信号通路改善2型糖尿病大鼠心肌缺血/再灌注损伤的机制研究[J]. 海南医学院学报, 2022, 28:566-571, 578. [7] 王伊凡, 李思远, 张姣. 右美托咪定预处理通过PI3K/Akt/mTOR信号通路对心肌缺血再灌注大鼠心脏损伤和心肌组织自噬的影响[J]. 陕西医学杂志, 2023, 52:1299-1303. [8] 金辉, 肖志博, 葛树胜, 等. 右美托咪定联合七氟醚对糖尿病小鼠心肌缺血/再灌注损伤的保护作用[J]. 局解手术学杂志, 2022, 31:1032-1039. [9] Li J, Zhao Y, Zhou N, et al. Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in diabetes mellitus by inhibiting endoplasmic reticulum stress[J]. J Diabetes Res, 2019, 2019:7869318-7869329. [10] 秦小英, 刘慧, 韩冲芳, 等. 改善昼夜节律紊乱减轻糖尿病大鼠心肌缺血/再灌注损伤[J]. 基础医学与临床, 2024, 44:231-234. [11] Ke X, Zhang J, Huang X, et al. Construction and analysis of the lncRNA-miRNA-mRNA network based on competing endogenous RNA in atrial fibrillation[J]. Front Cardiovasc Med, 2022, 9:791156-791164. [12] Teaney NA, Cyr NE. FoxO1 as a tissue-specific therapeu-tic target for type 2 diabetes[J]. Front Endocrinol (Lausanne), 2023, 14:1286838-1286851. [13] Mao S, Zhao J, Zhang ZJ, et al. miR-183-5p overexpression in bone mesenchymal stem cell-derived exosomes protects against myocardial ischemia/reperfusion injury by targeting FOXO1[J]. Immunobiology, 2022, 227:152204-152216. |